Los puntos clave no están disponibles para este artículo en este momento.
Reduced TMT is an independent negative prognostic parameter in patients with progressive glioblastoma and may help to facilitate patient management by supporting patient stratification for therapeutic interventions or clinical trials.
Furtner et al. (2019) studied this question.